# Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

> **NCT04847726** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 110 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** contrast enhanced ultrasound
- **DIAGNOSTIC_TEST:** Dynamic CT
- **DIAGNOSTIC_TEST:** Liver MRI

## Key facts

- **NCT ID:** NCT04847726
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-09
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2021-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04847726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04847726, "Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04847726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*